{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:34:50Z","timestamp":1776839690583,"version":"3.51.2"},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1507\/endocrj.k06-156","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T05:49:33Z","timestamp":1184824173000},"page":"465-470","source":"Crossref","is-referenced-by-count":26,"title":["Fibroblast Growth Factor-23 (FGF23) in Patients with Transient Hypoparathyroidism: Its Important Role in Serum Phosphate Regulation"],"prefix":"10.1507","volume":"54","author":[{"given":"Hiroyuki","family":"YAMASHITA","sequence":"first","affiliation":[{"name":"Noguchi Thyroid Clinic and Hospital Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"YAMAZAKI","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Labs, Kirin Brewery Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"HASEGAWA","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Labs, Kirin Brewery Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeyoshi","family":"YAMASHITA","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Labs, Kirin Brewery Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"FUKUMOTO","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Endocrinology, Department of Internal Medicine, Tokyo University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"SHIGEMATSU","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Blood Purification Medicine, Wakayama Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro James","family":"KAZAMA","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medicine and Dental Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"FUKAGAWA","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis Center, Kobe University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"NOGUCHI","sequence":"additional","affiliation":[{"name":"Noguchi Thyroid Clinic and Hospital Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Quarles LD, Drezner MK (2001) Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem. J Clin Endocrinol Metab 86: 494-496.","DOI":"10.1210\/jcem.86.2.7302"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18: 1227-1234.","DOI":"10.1359\/jbmr.2003.18.7.1227"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/81664"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302304"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.101545198"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fukumoto S, Yamashita T (2002) Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Curr Opin Nephrol Hypertens 11: 385-389.","DOI":"10.1097\/00041552-200207000-00003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Larsson T, Zahradnik R, Lavigne J, Ljunggren O, Juppner H, Jonsson KB (2003) Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 148: 269-276.","DOI":"10.1530\/eje.0.1480269"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318399"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-004-0589-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429-435.","DOI":"10.1359\/JBMR.0301264"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamashita H, Yamashita T, Miyamoto M, Shigematsu T, Kazama JJ, Shimada T, Yamazaki Y, Fukumoto S, Fukagaw M, Noguchi S (2004) Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol 151: 55-60.","DOI":"10.1530\/eje.0.1510055"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S (2005) Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation. J Clin Endocrinol Metab 90: 4211-4215.","DOI":"10.1210\/jc.2004-2498"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0724"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Reinhardt TA, Horst RL, Orf JW, Hollis BW (1984) A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58: 91-98.","DOI":"10.1210\/jcem-58-1-91"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021105"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64: 2272-2279.","DOI":"10.1046\/j.1523-1755.2003.00328.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65: 1943-1946.","DOI":"10.1111\/j.1523-1755.2004.00604.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M (2004) Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44: 250-256.","DOI":"10.1053\/j.ajkd.2004.04.029"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M (2004) Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 44: 481-487.","DOI":"10.1016\/S0272-6386(04)00817-0"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1039"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91: 3144-3149.","DOI":"10.1210\/jc.2006-0021"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202527200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Murer H, Hernando N, Forster I, Biber J (2000) Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 80: 1373-1409.","DOI":"10.1152\/physrev.2000.80.4.1373"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/3\/54_3_465\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:44:24Z","timestamp":1618296264000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/3\/54_3_465\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k06-156","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}